A Healthy Volunteer Study of PBI-4050

Clinical trial NCT04695041 · COMPLETED

Trial details

NCT number: NCT04695041
Sponsor: Liminal BioSciences Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Fibrosis Inflammation

Start date: 2020-12-09
Primary completion: 2021-10-05
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.